The deal gives Olympus access to BioProtect’s commercially available implant system designed to protect healthy tissue during radiation therapy.
The robot-assisted technologies under this agreement respond directly to this challenge by improving clinical outcomes and reducing procedural complications.
The platform serves multiple surgical disciplines, including arthroscopy, bariatric surgery, general surgery, gynecology, hepatopancreatobiliary transplant procedures, thoracic surgery, and urology.
These investments will focus primarily on companies developing breakthrough technologies in gastrointestinal (GI), urology, and respiratory care.